Evidence map›Paper›PMID 31410813›Full record

ArticleJournal of general internal medicine2019

Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer.

Louise M Henderson, Laura Ichikawa, Diana S M Buist, Janie M Lee, Mary Bush, Dianne Johnson, Tracy Onega, Larissa Nekhlyudov, Karla Kerlikowske, Diana L Miglioretti and 2 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of general internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02212834 (Comparative Effectiveness of Surveillance Modalities in Breast Cancer Survivors), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02212834 completednot on this map

Comparative Effectiveness of Surveillance Modalities in Breast Cancer Survivors

TypeobservationalSponsorKaiser PermanenteRan2013 to 2016Enrolled36,444ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Louise M HendersonDepartment of Radiology, The University of North Carolina Chapel Hill NC, Chapel Hill, NC, 27599-7515, USA. Louise_Henderson@med.unc.edu.
Laura IchikawaKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Diana S M BuistKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Janie M LeeDepartment of Radiology, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
Mary BushKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Dianne JohnsonKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Tracy OnegaDepartment of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Larissa NekhlyudovDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Karla KerlikowskeDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Diana L MigliorettiKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Brian L SpragueDepartment of Surgery, University of Vermont College of Medicine, Burlington, VT, USA.
Karen J WernliKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Diana L Miglioretti · 2011 to 2026
$52.9M
Vermont Screening Process Documentation UnitU54CA163303 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L · 2011 to 2017
$6.4M
NCI NIH HHS P01 CA154292NCI NIH HHS U54 CA163303
6 · The paper itself

Abstract

backgroundNational patterns of breast imaging in women with a personal history of breast cancer (PHBC) are unknown making evaluation of annual surveillance recommendations a challenge.

objectiveTo describe variation in use of mammography and breast magnetic resonance imaging (MRI) examinations beginning 6 months after diagnosis among women with PHBC in US community practice. We report on the breast imaging indication, imaging intervals, and time since breast cancer diagnosis by examination type.

designLongitudinal study using cross-sectional data.

settingBreast Cancer Surveillance Consortium breast imaging facilities.

participants19,955 women diagnosed between 2005 and 2012 with AJCC stage 0-III incident breast cancer who had 69,386 mammograms and 3,553 breast MRI examinations from January 2005 to September 2013; median follow-up of 37.6 months (interquartile range, 22.1-60.7). MAIN MEASURES: Breast imaging indication, imaging intervals, and time since breast cancer diagnosis by examination type. KEY

resultsAmong women with a PHBC who received breast imaging, 89.4% underwent mammography alone, 0.8% MRI alone, and 10.3% had both mammography and MRI. About half of mammograms and MRIs were indicated for surveillance vs. diagnostic, with an increase in the proportion of surveillance exams as time from diagnosis increased (mammograms, 45.7% at 1 year to 72.2% after 5 years; MRIs, 54.8% at 1 year to 78.6% after 5 years). In the first post-diagnosis period, 32.8% of women had > 2 breast imaging examinations and of these, 65.8% were less than 6 months apart. During the first 5-year post-diagnosis, the frequency of examinations per year decreased and the interval between examinations shifted towards annual examinations.

conclusionIn women with a PHBC who received post-diagnosis imaging, a third underwent multiple breast imaging examinations per year during the first 2-year post-diagnosis despite recommendations for annual exams. As time since diagnosis increases, imaging indication shifts from diagnostic to surveillance.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsCancer SurvivorsCross-Sectional StudiesFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMammographyMiddle AgedRegistriesYoung Adultbreast cancerbreast magnetic resonance imagingcancer surveillancecancer survivorshipmammography

Identifiers

PMID31410813
PMCPMC6816668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.